Skip to main content

Table 2 Correlation of ΔHbA1c with baseline variables

From: Predictors of acarbose therapeutic efficacy in newly diagnosed type 2 diabetes mellitus patients in China

Variables

ΔHbA1c at week 24

ΔHbA1c at week 48

r

P

r

P

Age (years)

0.066

0.242

−0.021

0.715

Disease duration (months)

0.056

0.321

0.095

0.102

Weight (kg)

−0.035

0.536

−0.017

0.773

BMI (kg/m2)

−0.067

0.238

−0.075

0.201

SBP (mmHg)

0.011

0.845

−0.017

0.766

DBP (mmHg)

0.073

0.195

0.063

0.279

HbA1c (%)

−0.784

< 0.001

− 0.762

< 0.001

FPG (mmol/L)

−0.270

< 0.001

− 0.309

< 0.001

2 h PG (mmol/L)

−0.318

< 0.001

− 0.339

< 0.001

FINS (mU/L)

−0.040

0.482

0.054

0.368

2 h INS (mU/L)

0.043

0.450

0.002

0.976

HOMA-IR

− 0.074

0.201

−0.069

0.249

HOMA-B

0.097

0.091

0.115

0.054

IGI

0.180

0.002

0.150

0.012

AUCglucagon (pg/mL*min)

−0.093

0.104

−0.095

0.107

AUCinsulin (uIU/mL*min)

0.099

0.089

0.023

0.698

AUCGLP- 1 (pmol*min)

−0.013

0.823

−0.049

0.406

  1. ΔHbA1c reduction in HbA1c